545 related articles for article (PubMed ID: 8200979)
21. Free fatty acids (FFA), a link between obesity and insulin resistance.
Boden G
Front Biosci; 1998 Feb; 3():d169-75. PubMed ID: 9450985
[TBL] [Abstract][Full Text] [Related]
22. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
[TBL] [Abstract][Full Text] [Related]
23. Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans.
Laurent D; Petersen KF; Russell RR; Cline GW; Shulman GI
Am J Physiol; 1998 Jan; 274(1):E130-8. PubMed ID: 9458758
[TBL] [Abstract][Full Text] [Related]
24. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations.
Vaag AA; Handberg A; Skøtt P; Richter EA; Beck-Nielsen H
Eur J Endocrinol; 1994 Jan; 130(1):70-9. PubMed ID: 8124481
[TBL] [Abstract][Full Text] [Related]
25. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.
Ebeling P; Koivisto VA
Diabetologia; 1994 Feb; 37(2):202-9. PubMed ID: 8163056
[TBL] [Abstract][Full Text] [Related]
26. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
Rebrin K; Steil GM; Mittelman SD; Bergman RN
J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
[TBL] [Abstract][Full Text] [Related]
27. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
Piatti PM; Monti LD; Caumo A; Conti M; Magni F; Galli-Kienle M; Fochesato E; Pizzini A; Baldi L; Valsecchi G; Pontiroli AE
J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
[TBL] [Abstract][Full Text] [Related]
28. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
[TBL] [Abstract][Full Text] [Related]
29. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
30. Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo.
Jenkins AB; Storlien LH; Chisholm DJ; Kraegen EW
J Clin Invest; 1988 Jul; 82(1):293-9. PubMed ID: 3292587
[TBL] [Abstract][Full Text] [Related]
31. Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion.
Tuominen JA; Ebeling P; Vuorinen-Markkola H; Koivisto VA
Diabet Med; 1997 Apr; 14(4):301-8. PubMed ID: 9113484
[TBL] [Abstract][Full Text] [Related]
32. Metabolic control analysis of insulin-stimulated glucose disposal in rat skeletal muscle.
Jucker BM; Barucci N; Shulman GI
Am J Physiol; 1999 Sep; 277(3):E505-12. PubMed ID: 10484363
[TBL] [Abstract][Full Text] [Related]
33. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H
Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
[TBL] [Abstract][Full Text] [Related]
34. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
[TBL] [Abstract][Full Text] [Related]
35. Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI.
Christopher MJ; Rantzau C; Ward GM; Alford FP
Am J Physiol; 1995 Mar; 268(3 Pt 1):E410-21. PubMed ID: 7900787
[TBL] [Abstract][Full Text] [Related]
36. Interaction between glucose and free fatty acid metabolism in human skeletal muscle.
Kelley DE; Mokan M; Simoneau JA; Mandarino LJ
J Clin Invest; 1993 Jul; 92(1):91-8. PubMed ID: 8326021
[TBL] [Abstract][Full Text] [Related]
37. Increased lipid oxidation but normal muscle glycogen response to epinephrine in humans with IDDM.
Cohen N; Halberstam M; Rossetti L; Shamoon H
Am J Physiol; 1996 Aug; 271(2 Pt 1):E284-93. PubMed ID: 8770022
[TBL] [Abstract][Full Text] [Related]
38. Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans.
Bonadonna RC; Groop LC; Zych K; Shank M; DeFronzo RA
Am J Physiol; 1990 Nov; 259(5 Pt 1):E736-50. PubMed ID: 2240211
[TBL] [Abstract][Full Text] [Related]
39. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.
Rossetti L; Giaccari A
J Clin Invest; 1990 Jun; 85(6):1785-92. PubMed ID: 2189891
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of lipolysis stimulates peripheral glucose uptake but has no effect on endogenous glucose production in HIV lipodystrophy.
Lindegaard B; Frøsig C; Petersen AM; Plomgaard P; Ditlevsen S; Mittendorfer B; Van Hall G; Wojtaszewski JF; Pedersen BK
Diabetes; 2007 Aug; 56(8):2070-7. PubMed ID: 17601993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
